NDC 70518-3913-2 - medroxyprogesterone acetate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-3913
- Requested NDC
- 70518-3913-2
- Package NDCs from labels
- 70518-3913-0, 70518-3913-2, 70518-3913-1
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2024-12-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Medroxyprogesterone Acetate Tablets, USP | REMEDYREPACK INC. | 2024-12-04 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-3913 | MEDROXYPROGESTERONE ACETATE TABLET [REMEDYREPACK INC.] | 6 | Unmatched | 20241206_e69019a5-90c0-4be7-ad1f-b8b44baa97e6.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Chain Drug Marketing Association Inc. | 2b490a08-149d-76ab-e063-6394a90a084f | 2025-01-09 | Warnings | T5L8T28FGP |
| A-5 | SUCROSE | DNA Labs, Inc. | 8e63f697-26c1-4518-acd3-5ea72cfa27f7 | 2025-01-09 | Warnings | C151H8M554 |
| Medroxyprogesterone Acetate Injectable Suspension | MEDROXYPROGESTERONE ACETATE | Hikma Pharmaceuticals USA Inc. | 0476eac5-d96c-4910-aa86-1ddeeefefe50 | 2025-01-08 | Boxed warning, Warnings, Adverse reactions | C2QI4IOI2G |
| Mineral Oil | MINERAL OIL | Safecor Health, LLC | ef182484-692e-4eb3-bcf1-3c990ec0d08e | 2025-01-08 | Warnings | T5L8T28FGP |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | PD-Rx Pharmaceuticals, Inc. | 437edd12-2c08-4df4-8cf7-64c47e4779ac | 2025-01-02 | Boxed warning, Warnings, Adverse reactions | 1000114 C2QI4IOI2G |
| Lubricant Eye PM | MINERAL OIL, WHITE PETROLATUM | Reliable 1 Laboratories LLC | baec8045-97fe-6f60-e053-2a95a90a050e | 2024-12-31 | Warnings | T5L8T28FGP |
| AD Medicated Rash | AD MEDICATED RASH | WellSpring Pharmaceutical Corporation | aac345bf-ea66-4f5b-a497-c24ea72f93ea | 2024-12-27 | Warnings | T5L8T28FGP |
| Gut Brain Spectrum | ABROTANUM (ARTEMISIA ABROTANUM), AETHUSA CYNAPIUM, BAPTISIA TINCTORIA, CICUTA VIROSA, CUPRUM METALLICUM, MEZEREUM, BUFO RANA, LAC MATERNA HUMANUM, SACCHARUM OFFICINALE, SEROTONIN (HYDROCHLORIDE), ALUMINA, CALCAREA PHOSPHORICA, CANDIDA ALBICANS, CARCINOSIN, LAC CANINUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, PROPIONIC ACID, SULPHUR, THUJA OCCIDENTALIS, FORMALINUM, MORBILLINUM | Energique, Inc. | adfee6ce-05b0-4955-bf5f-9612b8db4c78 | 2024-12-26 | Warnings | C151H8M554 |
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Pharmacy Value Alliance, LLC | 3803a61b-308a-14a9-e054-00144ff88e88 | 2024-12-20 | Warnings | T5L8T28FGP |
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Trifecta Pharmaceuticals USA LLC | c50cc6ad-e8a0-47c1-e053-2a95a90a4de6 | 2024-12-18 | Warnings | T5L8T28FGP |
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Trifecta Pharmaceuticals USA LLC | fe18fa61-83f9-8bf9-e053-6294a90a7585 | 2024-12-18 | Warnings | T5L8T28FGP |
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Trifecta Pharmaceuticals USA LLC | c59dcb2a-392b-670b-e053-2995a90a9682 | 2024-12-18 | Warnings | T5L8T28FGP |
| TheraCare Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Veridian Healthcare | fab95657-d257-e671-e053-6294a90a59e0 | 2024-12-18 | Warnings | T5L8T28FGP |
| Recticare Advanced | LIDOCAINE AND MINERAL OIL AND PHENYLEPHRINE HCL AND WHITE PETROLATUM | Ferndale Laboratories, Inc. | 209212a7-7b6e-4b26-9f31-0eeb76f026bf | 2024-12-17 | Warnings | T5L8T28FGP |
| Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Rugby | a5b5e0a9-eee9-2a1e-e053-2a95a90a464e | 2024-12-17 | Warnings | T5L8T28FGP |
| Dr. Butler Soothing Incontinence | PETROLATUM 36% | Beyond Health P.A. | d17a0c28-a5b7-4df0-e053-2995a90a8edd | 2024-12-15 | Warnings | T5L8T28FGP |
| Systane Nighttime | MINERAL OIL AND WHITE PETROLATUM | Alcon Laboratories, Inc. | 4689c59c-5721-3f91-6c85-e41501998fd0 | 2024-12-05 | Warnings | T5L8T28FGP |
| GenTeal Tears NIGHT-TIME | MINERAL OIL, WHITE PETROLATUM | Alcon Laboratories, Inc. | 9d5998a7-4f59-4293-87da-8419650a524d | 2024-12-05 | Warnings | T5L8T28FGP |
| Pure and Gentle | MINERAL OIL | Medline Industries, LP | 96d4cad5-0602-4c31-94ed-3117b4fd4a94 | 2024-11-26 | Warnings | T5L8T28FGP |
| 4718 Enema, Mineral Oil | 4718 ENEMA, MINERAL OIL | Dynarex | 9e51c852-9477-5cf5-e053-2a95a90a97db | 2024-11-20 | Warnings | T5L8T28FGP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.